Table 3.
Mean (SD) | Range | B | SE B | β | p-value | |
---|---|---|---|---|---|---|
Independent Variable | ||||||
VO2 max change | 2.32 (2.87) | −1.1 to 10.6 | .000004 | .0004 | .001 | .993 |
Controlling baseline PAR minutes | .00001 | .0004 | .003 | .977 | ||
Controlling age, gender, & condition | .00006 | .0004 | .017 | .895 | ||
VO2 max change X condition effect | .0003 | .0008 | .07 | .737 | ||
PAR total minutes change | 61.98 (109.80) | −150 to 340 | −.00002 | .00001 | −.25 | .041 |
Controlling baseline VO2 max | −.00002 | .00001 | −.26 | .035 | ||
Controlling age, gender, & condition | −.00003 | .00001 | −.29 | .016 | ||
PAR change X condition effect | .00002 | .00002 | .23 | .324 |
NOTE: All analyses control for baseline methylation on the linear composite of methylation on breast cancer-related CpG sites.